Recently, we developed a series of novel and patent amino-peptidase inhibit
ors with a homophthalimide skeleton. Among them, N-(2,6-diethylphenyl)homop
hthalimide (PIQ-22) possesses a specific aminopeptidase-inhibiting activity
more potent than that of bestatin or actinonin, as assayed In terms of hyd
rolysis of L-alanine 4-methylcoumaryl-7-amide (Ala-AMC) by human acute lymp
hoblastic leukemia MOLT-4 cells. We show here that PIQ-22 and its 2,6-dimet
hylphenyl derivative (PIQ-11) are more potent inhibitors of tumor cell inva
sion than bestatin and actinonin in a Matrigel assay using mouse melanoma B
16F10/L5 cells.